tiprankstipranks
Citius Pharmaceuticals (CTXR)
NASDAQ:CTXR
US Market
Want to see CTXR full AI Analyst Report?

Citius Pharmaceuticals (CTXR) Financial Statements

1,780 Followers

Citius Pharmaceuticals Financial Overview

Citius Pharmaceuticals's market cap is currently $17.35M. The company's EPS TTM is $-2.89; its P/E ratio is -0.51; Citius Pharmaceuticals is scheduled to report earnings on May 7, 2026, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Sep 25Sep 24Dec 23Sep 22Sep 21
Income Statement
Total Revenue$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit$ -214.25K$ -209.61K$ -194.32K$ -179.68K$ -164.87K
Operating Income$ -38.53M$ -42.00M$ -36.73M$ -33.32M$ -23.53M
EBITDA$ -38.20M$ -38.64M$ -31.77M$ -32.88M$ -22.88M
Net Income$ -37.43M$ -39.14M$ -32.54M$ -33.64M$ -23.13M
Balance Sheet
Cash & Short-Term Investments$ 4.25M$ 3.25M$ 26.48M$ 41.71M$ 70.07M
Total Assets$ 130.94M$ 116.65M$ 103.61M$ 114.00M$ 142.43M
Total Debt$ 1.81M$ 262.87K$ 481.25K$ 678.23K$ 855.47K
Net Debt$ -2.44M$ -2.99M$ -26.00M$ -41.03M$ -69.22M
Total Liabilities$ 53.41M$ 42.55M$ 12.18M$ 10.57M$ 9.65M
Stockholders' Equity$ 67.55M$ 70.08M$ 90.83M$ 102.83M$ 132.18M
Cash Flow
Free Cash Flow$ -26.55M$ -28.20M$ -29.06M$ -28.36M$ -64.26M
Operating Cash Flow$ -26.55M$ -28.20M$ -29.06M$ -28.36M$ -24.25M
Investing Cash Flow$ -5.75M$ -5.00M$ 0.00$ 0.00$ -40.01M
Financing Cash Flow$ 33.30M$ 9.97M$ 13.83M$ 0.00$ 120.47M
Currency in USD

Citius Pharmaceuticals Earnings and Revenue History

Citius Pharmaceuticals Debt to Assets

Citius Pharmaceuticals Cash Flow

Citius Pharmaceuticals Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.